Forsta Ap Fonden Dexcom Inc Transaction History

Forsta Ap Fonden

$14.8 Billion
Q2 2025

A detailed history of Forsta Ap Fonden transactions in Dexcom Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 90,500 shares of DXCM stock, worth $6.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

90,500

Previous 88,100 2.72%

Holding current value

$6.01 Million

Previous $6.02 Million 31.3%

% of portfolio

0.05%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$59.83 - $87.57 $143,592 - $210,167	2,400 Added 2.72%	90,500 $7.9 Million
Q1 2025 May 12, 2025	BUY	$67.74 - $90.75 $338,700 - $453,750	5,000 Added 6.02%	88,100 $6.02 Million
Q4 2024 Jan 23, 2025	SELL	$65.68 - $81.01 $39,408 - $48,606	-600 Reduced 0.72%	83,100 $6.46 Million
Q3 2024 Oct 24, 2024	BUY	$64.0 - $116.06 $761,600 - $1.38 Million	11,900 Added 16.57%	83,700 $5.61 Million
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $3.33 Million - $4.24 Million	-30,200 Reduced 29.61%	71,800 $8.14 Million
Q1 2024 May 07, 2024	BUY	$114.22 - $140.1 $868,072 - $1.06 Million	7,600 Added 8.05%	102,000 $14.1 Million
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $211,372 - $347,648	-2,800 Reduced 2.88%	94,400 $11.7 Million
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $172,120 - $275,860	-2,000 Reduced 2.02%	97,200 $9.07 Million
Q2 2023 Aug 03, 2023	BUY	$112.47 - $130.98 $2.49 Million - $2.89 Million	22,100 Added 28.66%	99,200 $12.7 Million
Q1 2023 Apr 21, 2023	SELL	$104.0 - $122.92 $1.4 Million - $1.66 Million	-13,500 Reduced 14.9%	77,100 $8.96 Million
Q4 2022 Feb 02, 2023	BUY	$84.98 - $122.67 $1.09 Million - $1.57 Million	12,800 Added 16.45%	90,600 $10.3 Million
Q3 2022 Oct 17, 2022	SELL	$76.35 - $94.18 $198,509 - $244,868	-2,600 Reduced 3.23%	77,800 $6.27 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $4.17 Million - $8.15 Million	61,300 Added 320.94%	80,400 $5.99 Million
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $122,304 - $169,259	-1,300 Reduced 6.37%	19,100 $9.77 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $51,948 - $65,128	400 Added 2.0%	20,400 $11 Million
Q3 2021 Nov 10, 2021	SELL	$106.71 - $143.18 $320,130 - $429,540	-3,000 Reduced 13.04%	20,000 $10.9 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $275,366 - $366,962	3,400 Added 17.35%	23,000 $9.82 Million
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $33,916 - $41,896	400 Added 2.08%	19,600 $7.04 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $483,600 - $647,900	6,200 Added 47.69%	19,200 $7.1 Million
Q3 2020 Oct 22, 2020	BUY	$95.51 - $112.95 $171,918 - $203,310	1,800 Added 16.07%	13,000 $5.36 Million
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $18,804 - $31,602	300 Added 2.75%	11,200 $4.54 Million
Q1 2020 May 04, 2020	BUY	$47.79 - $75.63 $520,911 - $824,367	10,900 New	10,900 $2.94 Million

Others Institutions Holding DXCM

# of Institutions

1,109

Shares Held

370M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account